Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - MARIZYME INC | f10q093020_ex31z2.htm |
| 10-Q - FORM 10-Q QUARTERLY REPORT - MARIZYME INC | f10q093020_10q.htm |
| EX-32.2 - EXHIBIT 32.2 SECTION 906 CERTIFICATION - MARIZYME INC | f10q093020_ex32z2.htm |
| EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - MARIZYME INC | f10q093020_ex31z1.htm |
| EX-10.6 - EXHIBIT 10.6 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH BRUCE HARMON - MARIZYME INC | f10q093020_ex10z6.htm |
| EX-10.5 - EXHIBIT 10.5 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH TERRY BROSTOW - MARIZYME INC | f10q093020_ex10z5.htm |
| EX-10.4 - EXHIBIT 10.4 INDEMNIFICATION AGREEMENT DATED NOVEMBER 1, 2020 WITH JAMES SAPIRST - MARIZYME INC | f10q093020_ex10z4.htm |
Exhibit 32.1
CERTIFICATION OF
PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
I, James Sapirstein, Executive Chairman of Marizyme, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 16, 2020 | By: | /s/ James Sapirstein |
|
| James Sapirstein Executive Chairman (Principal Executive Officer) |